Ariad Pharmaceuticals Inc fka ARIA

[JJM760]

I am curious. What are your reasons for NOT lightening up?

I will take a swing here.

Because if Ponatinib gets any decent % of the front line and 113 starts to look real good, in a few years this POS has a better than decent chance of landing somewhere in the $50 range.

At that number, with the ludicrous position I have, I could shoot for a 10% annual return and be an extremely comfortable professional little league coach for my young kids or a professional 12 handicap golfer or a professional beach bum. You get the point.

I know that's possibly the dumbest thing you have ever heard, but that is why I haven't sold my shares. I might trim 30% at $20, which I believe will be here by fall. I am open to all suggestions.

EDIT: BTW, I don't believe that the chances of Ariad's PPS being much lower than $18 in a few years are very high. So I sit and wait and monitor every possible piece of info I can to try and gain some incite into the 113 trial and the future of Ponatinib. If some large pharma would like to come along and make an offer and put in a nice floor for the PPS, I would not be too upset.